Please select the option that best describes you:
Topics:
Gynecologic Cancers • Ovarian Cancer
Do you test ovarian cancer tumors for targetable biomarkers (e.g., HER2, folate receptor, MMR) at the time of primary diagnosis or at time of recurrence?
If you send it at the time of recurrence, do you try to send a new tissue sample or use archival slides from their primary surgery?